Primarycare Diabetes is categorized under Internal Medicine Doctors in Syracuse, NY and active since 2010.
Primarycare Diabetes was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mary Eggleston, Office Manager at the company’s single location by writing to 1000 East Genesee St # 401, Syracuse, New York NY 13210 or by phoning (315) 471-1001. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Primarycare Diabetes |
| Contact Person: | Mary Eggleston, Office Manager |
| Address: | 1000 East Genesee St # 401, Syracuse, New York 13210 |
| Phone Number: | (315) 471-1001 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Primarycare Diabetes was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mary Eggleston, Office Manager for inquiries that concern Primarycare Diabetes by calling the company number (315) 471-1001, as your correspondence is most welcome. Additionally, the physical location of the single location of Primarycare Diabetes can be found at the coordinates 43.046735,-76.136565 as well as the street address 1000 East Genesee St # 401 in Syracuse, New York 13210.
For its online presence, you may visit Primarycare Diabetes’s website at and engage with its social media outlets through on Twitter and on Facebook.